|
9451 |
The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study
Enthalten in Graefe's archive for clinical and experimental ophthalmology Bd. 242, 7.7.2004, Nr. 8, date:8.2004: 654-660
|
|
|
|
9452 |
The Influence of Oral Cannabidiol on 24-h Ambulatory Blood Pressure and Arterial Stiffness in Untreated Hypertension: A Double-Blind, Placebo-Controlled, Cross-Over Pilot Study
Enthalten in Advances in therapy Bd. 40, 8.6.2023, Nr. 8, date:8.2023: 3495-3511
|
|
|
|
9453 |
The influence of probiotics on genital high-risk human papilloma virus clearance and quality of cervical smear: a randomized placebo-controlled trial
Enthalten in BMC women's health Bd. 19, 24.7.2019, Nr. 1, date:12.2019: 1-7
|
|
|
|
9454 |
The influence of progressive-chronic and acute sodium bicarbonate supplementation on anaerobic power and specific performance in team sports: a randomized, double-blind, placebo-controlled crossover study
Enthalten in Nutrition & metabolism Bd. 17, 24.5.2020, Nr. 1, date:12.2020: 1-15
|
|
|
|
9455 |
The INIS Study. International Neonatal Immunotherapy Study: non-specific intravenous immunoglobulin therapy for suspected or proven neonatal sepsis: an international, placebo controlled, multicentre randomised trial
Enthalten in BMC pregnancy and childbirth Bd. 8, 08.12.2008, Nr. 1, date:12.2008: 1-13
|
|
|
|
9456 |
The interplay of exercise, placebo and nocebo effects on experimental pain
Enthalten in Scientific reports Bd. 8, 3.10.2018, Nr. 1, date:12.2018: 1-11
|
|
|
|
9457 |
The key role of Shenyan Kangfu tablets, a Chinese patent medicine for diabetic nephropathy: study protocol for a randomized, double-blind and placebo-controlled clinical trial
Enthalten in Trials Bd. 14, 5.6.2013, Nr. 1, date:12.2013: 1-8
|
|
|
|
9458 |
The LIFE-MET trial: effect of insulin sensitization on pubertal progression following lifestyle intervention and/or treatment with metformin in girls with early puberty and overweight: study protocol for a randomized, placebo-controlled trial
Enthalten in Trials Bd. 26, 25.11.2025, Nr. 1, date:12.2025: 1-14
|
|
|
|
9459 |
The LIFT trial: study protocol for a double-blind, randomised, placebo-controlled trial of K+-binder Lokelma for maximisation of RAAS inhibition in CKD patients with heart failure
Enthalten in BMC nephrology Bd. 22, 6.7.2021, Nr. 1, date:12.2021: 1-9
|
|
|
|
9460 |
The Lipid lowering and Onset of Renal Disease (LORD) Trial: A randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease
Enthalten in BMC nephrology Bd. 9, 18.3.2008, Nr. 1, date:12.2008: 1-6
|
|
Administration
